Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sandoz
Pharma
Sandoz's biosimilar to Biogen's Tysabri hits the US after delay
Biogen has had two years to gear up for the impending launch of Sandoz's biosimilar Tyruko, which earned FDA approval in 2023.
Zoey Becker
Nov 17, 2025 11:12am
Trump's Swiss trade deal caps pharma tariffs at 15%
Nov 17, 2025 10:30am
Settlement allows Sandoz to launch Eylea biosimilar in late 2026
Sep 9, 2025 10:30am
CSL's Venofer finally faces generic competition
Aug 13, 2025 2:06pm
Sandoz pumps $440M into another Slovenia biosimilar plant
Jul 2, 2025 9:10am
Sandoz recalls one lot of cefazolin due to mispackaging
Jun 30, 2025 9:01am
